Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024
Twist Bioscience (NASDAQ: TWST) has announced it will release its fiscal 2024 fourth quarter and full year financial results on November 18, 2024, before market opening. The company will host a conference call and live audio webcast for analysts and investors at 8:00 AM Eastern Time. Participants interested in joining via telephone must register through the company's Investor Relations website. A webcast replay will be available for two weeks following the call.
Twist Bioscience (NASDAQ: TWST) ha annunciato che rilascerà i suoi risultati finanziari del quarto trimestre e dell'intero anno fiscale 2024 il 18 novembre 2024, prima dell'apertura del mercato. L'azienda organizzerà una chiamata in conferenza e una trasmissione audio dal vivo per analisti e investitori alle 8:00 AM, ora dell'Est. I partecipanti interessati a partecipare telefonicamente devono registrarsi attraverso il sito web delle Relazioni con gli Investitori dell'azienda. Una riproduzione della trasmissione sarà disponibile per due settimane dopo la chiamata.
Twist Bioscience (NASDAQ: TWST) ha anunciado que publicará sus resultados financieros del cuarto trimestre y del año fiscal 2024 el 18 de noviembre de 2024, antes de la apertura del mercado. La empresa realizará una conferencia telefónica y una transmisión de audio en vivo para analistas e inversores a las 8:00 AM, hora del Este. Los participantes interesados en unirse por teléfono deben registrarse a través del sitio web de Relaciones con Inversores de la empresa. Una repetición de la transmisión estará disponible durante dos semanas después de la llamada.
트위스트 바이오사이언스 (NASDAQ: TWST)는 2024 회계연도 4분기 및 전체 연도 재무 결과를 2024년 11월 18일 시장 개장 전 발표할 예정이라고 발표했습니다. 이 회사는 동부 표준시 기준으로 오전 8시에 분석가와 투자자를 위한 전화 회의 및 실시간 오디오 웹캐스트를 개최합니다. 전화로 참여하기를 원하는 참가자는 회사의 투자자 관계 웹사이트를 통해 등록해야 합니다. 방송 녹화는 통화 후 2주 동안 제공됩니다.
Twist Bioscience (NASDAQ: TWST) a annoncé qu'il publiera ses résultats financiers du quatrième trimestre et de l'exercice 2024 le 18 novembre 2024, avant l'ouverture des marchés. L'entreprise tiendra une conférence téléphonique et un webinaire audio en direct pour les analystes et les investisseurs à 8h00, heure de l'Est. Les participants intéressés à rejoindre par téléphone doivent s'inscrire via le site web de la relations avec les investisseurs de la société. Un enregistrement du webinaire sera disponible pendant deux semaines suivant l'appel.
Twist Bioscience (NASDAQ: TWST) hat angekündigt, dass sie ihre Finanzergebnisse für das vierte Quartal und das Gesamtjahr 2024 am 18. November 2024 vor Markteröffnung veröffentlichen wird. Das Unternehmen wird um 8:00 Uhr Eastern Time eine Telefonkonferenz und ein Live-Audio-Webcast für Analysten und Investoren veranstalten. Interessierte Teilnehmer, die per Telefon teilnehmen möchten, müssen sich über die Investor-Relations-Website des Unternehmens registrieren. Eine Wiederholung des Webcasts wird zwei Wochen nach dem Anruf verfügbar sein.
- None.
- None.
Company to host conference call at 8:00 AM ET
The conference call will be webcast live through the Investor Relations section under the “Company” tab at www.twistbioscience.com. Those parties interested in participating via telephone must register on the Company’s Investor Relations website or by clicking here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Follow us on LinkedIn | X | YouTube | Instagram
View source version on businesswire.com: https://www.businesswire.com/news/home/20241024652806/en/
For Investors:
Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com
For Media:
Amanda Houlihan
Communications Manager
774-265-5334
ahoulihan@twistbioscience.com
Source: Twist Bioscience Corporation
FAQ
When will Twist Bioscience (TWST) report its Q4 and full year 2024 earnings?
What time is Twist Bioscience's (TWST) Q4 2024 earnings call?